AIM ImmunoTech Inc (NYSE American:AIM)

2.13
Delayed Data
As of Oct 23
 +0.05 / +2.40%
Today’s Change
0.38
Today|||52-Week Range
7.11
+291.54%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues133.0K92.0K437.0K367.0K
 
 
 
 
 
Cost of Goods Sold623.0K1.1M179.0K424.5K
 
 
 
 
 
Depreciation And Amortization975.0K1.2M1.0M919.0K
 
 
 
 
 
 
Operating ExpensesGross Income-1.5M-2.2M-746.0K-976.5K
 
 
 
 
 
General Expenses15.0M11.5M10.7M10.5M
 
 
 
 
 
Research And Development7.8M5.0M4.1M4.7M
 
 
 
 
 
Total Operating Expenses16.6M13.8M11.8M11.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-16.4M-13.7M-11.4M-11.5M
 
 
 
 
 
Extraordinary Credit0.003.3M2.4M1.6M
 
 
 
 
Extraordinary Charge-315.0K-134.0K-7.0K-623.0K
 
 
 
 
 
Interest Expense On Debt3.0K0.00139.0K502.0K
 
 
 
 
Other Expenses1.2M2.9M791.0K1.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.2M-7.5M-8.3M-9.8M
 
 
 
 
 
Net Income-15.2M-7.5M-8.3M-9.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS447.3K495.9K651.7K1.0M
 
 
 
 
 
Shares To Calculate EPS Diluted447.3K495.9K651.7K1.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$31.68-$14.96-$12.76-$9.68
 
 
 
 
 
EPS Diluted-$31.68-$14.96-$12.76-$9.77